Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I feel your pain. The constant pivots are brutal and it makes it impossible to focus on actual R&D or long-term goals. Management keeps talking about efficiency and streamlining, but all it really does is burn out the people who are actually keeping the lab running. After the last few rounds, the culture feels completely hollow. You are definitely not alone in feeling this way, and it’s become common to just keep your head down and look for a way out rather than waiting for the next round of restructuring.
Look, it is just business as usual in this industry, even if it feels incredibly personal when you're in the thick of it. Bio-Rad is clearly pivoting to stay competitive, and unfortunately, headcount is always the first lever they pull to satisfy the analysts. It sucks to see good people go, but if you're tired of the cycle, it might be time to stop waiting for things to stabilize and start looking at competitors. Things rarely get better once the 'reorg' culture takes deep root in a company like this.